MedicinMan November 2014
MedicinMan November 2014
Tuesday, April 28, 2026
28.7
C
Bengaluru
Hot topics
Is Pharma’s Business Model like McDonald’s? ...
Is Pharma’s business model like McDonald’s? Doing things over & over again without innovation?
McDonald’s is famous for its Hamburger University, a training facility at the McDonald’s Corporation global headquarters in Chicago, Illinois. It instructs high-potential restaurant managers in restaurant management.
More than 5,000 students attend Hamburger University each year and over 275,000 people have graduated with a degree in Hamburgerology.
Sound familiar? Pharma’s training has been on similar lines – hire people continuously and put them through the grind of mugging up essentials of drugs for diseases that the particular company sells.
While the McDonald’s model is ideal for its business of replication, it has outlived its utility in healthcare and drug companies are in danger of being reduced to mere suppliers of drugs to new digital platform businesses unless they learn to innovate.
Pharma Marketing in the New Age
Inside this Issue
1. Conference Notes: Pharma Marketing in the New...
Worldclass Healthcare But Out of Reach for Most Indians?
When an eminent cardiologist like Dr. Sunil Chandy—former Director...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Can Indian Doctors and Patients Trust Generics Over Branded Generics? ...
The ongoing debate around branded versus generic medicines in...
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
Hot topics
When Biology Beats Willpower: The Rise of GLP‑1/GIP Therapies
“Lifestyle advice often asks patients to fight powerful evolutionary...
Digital Darwinism or Digital Expert – The Choice for Indian Pharma is Clear
It is heartening to see that Pharma marketers have...
Human Library – Reading People Through Their Life’s Experiences
Human beings have the innate desire to create and...
Eli Lilly’s $6.5 Billion Houston Bet: A Strategic Play in U.S. Manufacturing, Policy, and the Next Wave of Obesity Treatment
When Eli Lilly announced plans to build a $6.5...
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Newsletter
Get important news delivered directly to your inbox and stay connected!